COOK INC GUNTHER TULIP FEMORAL VENA CAVA FILTER SET; DTK FILTER, INTRAVASCULAR, CARDIOVASCULAR
|
Back to Search Results |
|
Model Number G33016 |
Device Problems
Obstruction of Flow (2423); Structural Problem (2506); Device Tipped Over (2589)
|
Patient Problems
Erosion (1750); Internal Organ Perforation (1987); Perforation of Vessels (2135); Stenosis (2263); Anxiety (2328); Obstruction/Occlusion (2422); Thrombosis/Thrombus (4440)
|
Event Type
Injury
|
Manufacturer Narrative
|
The previous medwatch report was submitted by william cook europe under manufacturer report reference# (b)(4).Additional information provided determined that this device was manufactured by cook inc.With the submission of this initial medwatch report, cook inc.Informs that all future submissions regarding this complaint will be handled under the manufacturer report reference number of this initial medwatch report.Initial reporter occupation: non-healthcare professional.Investigation: the following allegations have been investigated: organ/vena cava perforation, stenosis, occlusion/thrombus, tilt, erosion.Investigation is reopened due to additional information provided.The reported allegations have been further investigated based on the information provided to date.Filter interacts with ivc wall, e.G.Penetration/perforation/embedment.This may be either symptomatic or asymptomatic.Potential causes may include improper deployment; and (or) excessive force or manipulations near an in-situ filter (e.G., a surgical or endovascular procedure in the vicinity of a filter).Potential adverse events that may occur include, but are not limited to, the following: trauma to adjacent structures, vascular trauma, vena cava perforation, vena cava penetration.Ivc occlusion/ thrombosis, new dvt, ivc stenosis as a reported complication, is a known risk in relation to filter implant and is well documented in the clinical literature and in clinical practice guidelines.This is supported by the clinical evidence report established to assess available clinical data to identify and evaluate the clinical safety and performance of the cook vena cava filters.Potential adverse events that may occur include, but are not limited to, the following: vena cava occlusion or thrombosis, vena cava stenosis, deep vein thrombosis.Filter tilt has been reported.Potential causes may include filter placement in ivcs with diameters larger than those specified in these instructions for use; improper deployment; manipulations near an implanted filter (e.G., a surgical or endovascular procedure in the vicinity of a filter); and (or) a failed retrieval attempt.Excessive filter tilt may contribute to difficult or failed retrieval; vena cava wall penetration/perforation; and (or) result in loss of filter efficiency.Potential adverse events that may occur include, but are not limited to, the following: unacceptable filter tilt.Unknown if the reported erosion is directly related to the filter and unable to identify a corresponding failure mode at this point in time.(b)(4) devices in lot.No relevant notes on work order.The product is manufactured and inspected according to specifications.No evidence to suggest that this device was not manufactured according to specifications and nothing indicates that the filter did not perform as intended, e.G.Intended for the prevention of recurrent pulmonary embolism (pe) via placement in the vena cava.Cook will reopen its investigation if further information is received warranting supplementation in accordance with 21 c.F.R.803.56.This report includes information known at this time.A follow-up medwatch report will be submitted if additional relevant information becomes available.
|
|
Event Description
|
The patient received an implant on (b)(6) 2012 via the right internal jugular vein to prevent deep vein thrombosis (dvt)/pulmonary embolism (pe).The patient alleges tilt, vena cava perforation, and stenosis.The patient reportedly expired on (b)(6) 2020.Specific details surrounding the patient's expiration are currently unknown, and there is currently no reported allegation of wrongful death.Death certificate has been requested but not yet received.(b)(6) 2015, per a report from venogram; ¿impression: bilateral lower extremity and ivc venogram revealed extensive thrombus extending from the popliteal vein to the ivc and superior to the infrarenal filter.Chemical tpa and heparin administered and thrombectomy/thrombolysis initiated".(b)(6) 2015, per a report from venogram; ¿impression: successful thrombolysis of the right lower extremity with in-line flow involving the femoral and iliac veins.Complete conclusion despite thrombolysis overnight of the left femoral vein.Percutaneous balloon angioplasty was performed on the occluded segments and an infusion catheter was reinserted for repeat overnight thrombolysis.The patient should return to interventional radiology on (b)(6) 2015 for subsequent treatment.Patent iliac veins and inferior vena cava.¿ (b)(6) 2019, per a report from computed tomography; ¿findings: ivc filter has been placed within the abdomen and inferior vena cava.The tip is just below the level of the renal veins.There is minimal posterior angulation.The prongs are symmetric and intact with erosion through the ivc wall.There is no rupture.¿ "impression: benign-appearing placement of ivc filter with no acute findings".(b)(6) 2019, per a report from computed tomography 2; ¿ivc filter with: 4 mm mesenteric perforation.Tilting with the apex against the wall.Ivc stenosis.No fracture, or migration".
|
|
Manufacturer Narrative
|
Blank fields on this form indicate the information is unknown, unavailable, or unchanged.Investigation: the following allegations have been investigated: anxiety.Investigation is reopened due to additional information provided.The reported allegations have been further investigated based on the information provided to date.Unknown if the reported anxiety is directly related to the filter and unable to identify a corresponding failure mode at this point in time.20 devices in lot.No relevant notes on work order.The product is manufactured and inspected according to specifications.No evidence to suggest that this device was not manufactured according to specifications and nothing indicates that the filter did not perform as intended, e.G.Intended for the prevention of recurrent pulmonary embolism (pe) via placement in the vena cava.Cook will reopen its investigation if further information is received warranting supplementation in accordance with 21 c.F.R.803.56.This report includes information known at this time.A follow-up medwatch report will be submitted if additional relevant information becomes available.This report is required by the fda under 21 cfr part 803.This report is based on unconfirmed information submitted by others.Neither the submission of this report nor any statement made in it is intended to be an admission that any cook device is defective or malfunctioned, that a death or serious injury occurred, or that any cook device caused or contributed to or is likely to cause or contribute to a death or serious injury if a malfunction occurred.
|
|
Event Description
|
The patient alleges anxiety.
|
|
Search Alerts/Recalls
|
|
|